Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
BME Frontiers
|
October 18, 2023
Optical Detection of Distal Lung Enzyme Activity in Human Inflammatory Lung Disease
Alicia Megia-Fernandez, Adam Marshall, Ahsan R Akram, et al.
BME Frontiers
|
October 18, 2023
Erratum to "Optical Detection of Distal Lung Enzyme Activity in Human Inflammatory Lung Disease"
Alicia Megia-Fernandez, Adam Marshall, Ahsan R Akram, et al.
Science Translational Medicine
|
October 26, 2018
In situ identification of Gram-negative bacteria in human lungs using a topical fluorescent peptide targeting lipid A
Ahsan R Akram, Sunay V Chankeshwara, Emma Scholefield, et al.
American Journal of Respiratory Cell and Molecular Biology
|
October 28, 2021
Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19
Clark D Russell, Asta Valanciute, Naomi N Gachanja, et al.
Nature Communications
|
May 2, 2022
A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies
Jamie I Scott, Lorena Mendive-Tapia, Doireann Gordon, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 11, 2020
Molecular detection of Gram-positive bacteria in the human lung through an optical fiber-based endoscope
Bethany Mills, Alicia Megia-Fernandez, Dominic Norberg, et al.
The Lancet. Oncology
|
May 4, 2023
Defining the road map to a UK national lung cancer screening programme
Emma L O'Dowd, Richard W Lee, Ahsan R Akram, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 16, 2022
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)
Erin E Gaughan, Tom M Quinn, Andrew Mills, et al.
Ebiomedicine
|
February 13, 2022
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics
Tom M Quinn, Erin E Gaughan, Annya Bruce, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
BME Frontiers
|
October 18, 2023
Optical Detection of Distal Lung Enzyme Activity in Human Inflammatory Lung Disease
Alicia Megia-Fernandez, Adam Marshall, Ahsan R Akram, et al.
BME Frontiers
|
October 18, 2023
Erratum to "Optical Detection of Distal Lung Enzyme Activity in Human Inflammatory Lung Disease"
Alicia Megia-Fernandez, Adam Marshall, Ahsan R Akram, et al.
Science Translational Medicine
|
October 26, 2018
In situ identification of Gram-negative bacteria in human lungs using a topical fluorescent peptide targeting lipid A
Ahsan R Akram, Sunay V Chankeshwara, Emma Scholefield, et al.
American Journal of Respiratory Cell and Molecular Biology
|
October 28, 2021
Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19
Clark D Russell, Asta Valanciute, Naomi N Gachanja, et al.
Nature Communications
|
May 2, 2022
A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies
Jamie I Scott, Lorena Mendive-Tapia, Doireann Gordon, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 11, 2020
Molecular detection of Gram-positive bacteria in the human lung through an optical fiber-based endoscope
Bethany Mills, Alicia Megia-Fernandez, Dominic Norberg, et al.
The Lancet. Oncology
|
May 4, 2023
Defining the road map to a UK national lung cancer screening programme
Emma L O'Dowd, Richard W Lee, Ahsan R Akram, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 16, 2022
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)
Erin E Gaughan, Tom M Quinn, Andrew Mills, et al.
Ebiomedicine
|
February 13, 2022
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics
Tom M Quinn, Erin E Gaughan, Annya Bruce, et al.
Page
of 6